XML 37 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Business and Significant Accounting Policies (Tables)
6 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of Entities Under Common Control and Ownership

The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at March 31, 2024:

 

    Jurisdiction of      
Name of Entity   Incorporation    Relationship 
Hypha Labs, Inc.(formerly Digipath, Inc.)(1)   Nevada    Parent 
Digipath Labs, Inc.   Nevada    Subsidiary 
Digipath Labs CA, Inc. (2)   California    Subsidiary 
Digipath Labs S.A.S.(3)   Colombia    Subsidiary 
VSSL Enterprises, Ltd.(4)   Canada    Subsidiary 

 

(1) Holding company, which owns each of the wholly-owned subsidiaries. All subsidiaries shown above are wholly-owned by Hypha Labs, Inc., the parent company.
(2) Formed during the second fiscal quarter of 2021, but has not yet commenced significant operations.
(3) Formed during the first fiscal quarter of 2019, but has not yet commenced significant operations.
(4) Acquired on March 11, 2020.
Schedule of Effect of Potential Dilutive Issuances

The following table presents the effect of potential dilutive issuances for the three and six months ended March 31, 2024 and 2023:

 

   March 31, 2024   March 31, 2023   March 31, 2024   March 31, 2023 
   Three Months Ended   Six Months Ended 
   March 31, 2024   March 31, 2023   March 31, 2024   March 31, 2023 
                 
Net income (loss) attributable to common stockholders  $(56,708)  $(121,821)  $(197,689)  $(360,694)
Interest expense associated with convertible debt   -    -    -    - 
Net income (loss) for dilutive calculation  $(56,708)  $(121,821)   (197,689)   (360,694)
                     
Weighted average shares outstanding   92,083,084    82,296,820    89,576,328    82,257,534 
Dilutive effect of preferred stock   -    -    -    - 
Dilutive effect of convertible debt   -    -    -    - 
Dilutive effect of common stock warrants   -    -    -    - 
Weighted average shares outstanding for diluted net income (loss) per share   92,083,084    82,296,820    89,576,328    82,257,534